luminor

Paclitaxel eluting PTA balloon dilatation catheter
The DCB you need

PRODUCT FEATURES

Easy navigation

Small profiles

Short deflation times and wide size range (0.014”, 0.018” and 0.035” guidewire compatibilities)

Coating technology matters
Not all DCBs are the same

TransferTech, the iVascular proprietary nanotechnology that:

Has an ultrathin coating thanks to the nanodrop technology used to coat the balloons.

Ensures a durable coating due to its multilayer technology, with minimum drug loss during navigation.

Ensures a uniform artery treatment.

CLINICAL SUPPORT

Luminor has demonstrated its safety and efficacy in long term follow-up and in different indications:

EffPac Trial

Multicenter, randomized and controlled trial, Luminor vs POBA.

90.1% fTLR

at 3.5 years

TINTIN Trial

Prospective, multicenter trial, with Luminor and iVolution combined therapy in TASC C&D lesions.

89.4% fTLR

at 2 years

MERLION Trial

Prospective, multicenter trial, with Luminor and Angiolite BTK as bailout stenting in BTK.

81.6% fTLR

at 1 year

Other trials: BIBLIOS,LUMBRA,LUMIFOLLOW, SOL JAPAN, LUMINOR registry.

CLINICAL PRESENTATIONS AT CONGRESSES

EffPac Trial
3.5 years outcomes presented at LINC 2021

TINTIN Trial
2-year outcomes presented at LINC 2021

Get in touch with us

A sales representative will provide you with the requested information.

Contact with us